Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Whole-body protein balance refers to the net difference between the rates of total body protein synthesis and breakdown. It is not a single molecule or receptor but rather a physiological state describing whether the body is gaining, losing, or maintaining its overall protein mass[4][6]. This concept is central in nutrition science and clinical medicine for assessing nutritional status, muscle health, recovery from illness or trauma, and response to dietary interventions. Measurement often involves tracking nitrogen intake versus excretion (nitrogen balance), as proteins are the primary source of dietary nitrogen[5]. A positive whole-body protein balance indicates net tissue growth or repair; a negative one suggests catabolism or inadequate intake[4][6]. "Whole-body protein balance" is not a molecular target such as an enzyme, receptor, transporter, etc., but rather describes an aggregate physiological process involving many different proteins and pathways throughout the body. Therefore it should not be considered a canonical therapeutic target for drug development purposes—entries referring to it as such are incorrect[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Whole-body protein balance.